Monday, December 23, 2024
HomeTagsDSP-0390

DSP-0390

Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-0390

Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics